FCM
CELG.RT
FourWorld Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,000
| Closed | -$5.66M | – | 22 |
|
|
2024
Q4 | $5.66M | Hold |
100,000
| – | – | 2.94% | 4 |
|
|
2024
Q3 | $5.17M | Hold |
100,000
| – | – | 2.98% | 5 |
|
|
2024
Q2 | $4.15M | Hold |
100,000
| – | – | 2.49% | 7 |
|
|
2024
Q1 | $5.42M | Hold |
100,000
| – | – | 3.46% | 7 |
|
|
2023
Q4 | $5.13M | Hold |
100,000
| – | – | 2.76% | 5 |
|
|
2023
Q3 | $69K | Hold |
100,000
| – | – | 0.01% | 16 |
|
|
2023
Q2 | $69K | Buy |
+100,000
| New | +$69K | 0.01% | 13 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$69K | – | 18 |
|
|
2022
Q4 | $69K | Hold |
100,000
| – | – | 0.1% | 11 |
|
|
2022
Q3 | $69K | Hold |
100,000
| – | – | 0.11% | 10 |
|
|
2022
Q2 | $69K | Hold |
100,000
| – | – | 0.11% | 11 |
|
|
2022
Q1 | $69K | Buy |
+100,000
| New | +$69K | 0.04% | 13 |
|